Flunarizine 2HCl (BioDeep_00000399024)

   

natural product


代谢物信息卡片


Flunarizine hydrochloride

化学式: C26H28Cl2F2N2 (476.1597492)
中文名称: 盐酸氟桂利嗪
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1(=CC=C(C=C1)C(N2CCN(CC2)C/C=C/C3=CC=CC=C3)C4=CC=C(C=C4)F)F.Cl.Cl
InChI: 2*1H/b7-4+

描述信息

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers
D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
D000077264 - Calcium-Regulating Hormones and Agents
D049990 - Membrane Transport Modulators
C93038 - Cation Channel Blocker
Flunarizine dihydrochloride is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine dihydrochloride is a D2 dopamine receptor antagonist. Flunarizine dihydrochloride shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].

同义名列表

3 个代谢物同义名

Flunarizine hydrochloride; Flunarizine 2HCl; Flunarizine (dihydrochloride)



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Guo-Liang Shao, Shao-Lei Huang, Rui Li, Dian-Hui Yang, Meng-Meng Wang. The curative efficacy of auricular comprehensive therapy on menstrual migraine and its effect on serum prostaglandin. Zhen ci yan jiu = Acupuncture research. 2024 Feb; 49(2):177-184. doi: 10.13702/j.1000-0607.20221424. [PMID: 38413039]
  • Yan-Ying Xu, Zhi-Heng Yi, Xiao-Min Li, Dai Li, Lin Pan, Yi-Xin Dai, Xue-Feng Zhong, Juan Yan, Ping-Sheng Xu, Su-Mei Xu. Pharmacokinetics of Flunarizine Hydrochloride After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects. Clinical pharmacology in drug development. 2022 03; 11(3):341-347. doi: 10.1002/cpdd.1012. [PMID: 34472200]
  • Xiayang Xie, Kai Shang, Xuejing Li. Tuling Wendan Decoction combined with flunarizine in the treatment of migraine patients and the effect of intervention on serum cyclooxygenase-2, endothelin-1 and nitric oxide. Cellular and molecular biology (Noisy-le-Grand, France). 2020 Sep; 66(6):34-40. doi: 10.14715/cmb/2020.66.6.7. [PMID: 33040782]
  • Bingxin Wu, Hongyin Rao, Songbai Yang, Sanjin Cai, Lingjing Tan, Zhitao Feng, Zhigang Mei. Efficacy and safety of the classic Chinese herbal prescription Sanpian decoction on migraine: A meta-analysis. Explore (New York, N.Y.). 2020 Sep; 16(5):318-327. doi: 10.1016/j.explore.2020.05.006. [PMID: 32505521]
  • Manman Dai, Luyu Bai, Huimin Zhang, Qun Ma, Rui Luo, Fang Lei, Qingsong Fei, Ning He. A novel flunarizine hydrochloride-loaded organogel for intraocular drug delivery in situ: Design, physicochemical characteristics and inspection. International journal of pharmaceutics. 2020 Feb; 576(?):119027. doi: 10.1016/j.ijpharm.2020.119027. [PMID: 31953090]
  • Hua Dong, Hong-Yi Zhao, Jian-Wu Wang, Jing-Xian Han. [Observation on therapeutic effect and mechanism research of acupuncture on headache in the recovery phase of ischemic stroke]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion. 2019 Nov; 39(11):1149-53. doi: 10.13703/j.0255-2930.2019.11.003. [PMID: 31724347]
  • Abhaysingh Bhadoriya, Priyanka A Shah, Pranav S Shrivastav, Mallika Sanyal, Manish S Yadav. A high-throughput LC-MS/MS method for determination of flunarizine in human plasma: Pharmacokinetic study with different doses. Biomedical chromatography : BMC. 2019 Sep; 33(9):e4582. doi: 10.1002/bmc.4582. [PMID: 31077435]
  • Lijin Nie, Jiawei Cheng, Yuecai Wen, Jinhu Li. The Effectiveness of Acupuncture Combined with Tuina Therapy in Patients with Migraine. Complementary medicine research. 2019; 26(3):182-194. doi: 10.1159/000496032. [PMID: 30893677]
  • Jennifer Retzlaff, Kristina Thamm, Chandra C Ghosh, Wolfgang Ziegler, Hermann Haller, Samir M Parikh, Sascha David. Flunarizine suppresses endothelial Angiopoietin-2 in a calcium - dependent fashion in sepsis. Scientific reports. 2017 03; 7(?):44113. doi: 10.1038/srep44113. [PMID: 28276491]
  • Maria J Newton, Kaur Harjot. Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery. Anti-inflammatory & anti-allergy agents in medicinal chemistry. 2017; 15(3):204-220. doi: 10.2174/1871523015666161216141812. [PMID: 27993106]
  • Kegang Cao, Fang Han, Anji Lin, Wenming Yang, Jianjun Zhao, Hui Zhang, Yanbing Ding, Wei Xie, Yinping Xu, Tingmin Yu, Xinzhi Wang, Xiaosu Yang, Jiying Zhou, Qun Hou, Lihua Yu, Ying Gao. Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial. BMC complementary and alternative medicine. 2016 Sep; 16(?):356. doi: 10.1186/s12906-016-1321-8. [PMID: 27618916]
  • Mauricio Ramírez-Zamora, Carlos Ignacio Ortez-González. [Alternating hemiplegia of childhood. The first clinical case reported in El Salvador]. Revista de neurologia. 2013 Sep; 57(5):212-6. doi: NULL. [PMID: 23975527]
  • Ya-ting Tina Yang, Matthew Whiteman, Steven P Gieseg. HOCl causes necrotic cell death in human monocyte derived macrophages through calcium dependent calpain activation. Biochimica et biophysica acta. 2012 Feb; 1823(2):420-9. doi: 10.1016/j.bbamcr.2011.09.019. [PMID: 22008466]
  • Lin-Peng Wang, Xiao-Zhe Zhang, Jia Guo, Hui-Lin Liu, Yan Zhang, Cun-Zhi Liu, Jing-Hong Yi, Li-Ping Wang, Ji-Ping Zhao, Shan-Shan Li. Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial. Pain. 2011 Aug; 152(8):1864-1871. doi: 10.1016/j.pain.2011.04.006. [PMID: 21616596]
  • Stefano Caproni, Ilenia Corbelli, Luigi Alberto Pini, Maria Letizia Cupini, Paolo Calabresi, Paola Sarchielli. Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. Cephalalgia : an international journal of headache. 2011 Apr; 31(5):543-9. doi: 10.1177/0333102410392605. [PMID: 21216871]
  • Arunachalam Muthuraman, Sumeet Kumar Singla, Ajay Rana, Atinderjeet Singh, Shailja Sood. Reno-protective role of flunarizine (mitochondrial permeability transition pore inactivator) against gentamicin induced nephrotoxicity in rats. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2011 Mar; 131(3):437-43. doi: 10.1248/yakushi.131.437. [PMID: 21372541]
  • Zhijun Wang, Shuai Qian, Qizhi Zhang, Moses S S Chow. Quantification of meclizine in human plasma by high performance liquid chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2011 Jan; 879(1):95-9. doi: 10.1016/j.jchromb.2010.11.022. [PMID: 21163711]
  • Arunachalam Muthuraman, Shailja Sood, Sumeet Kumar Singla, Ajay Rana, Atinderjeet Singh, Amandeep Singh, Jai Singh. Ameliorative effect of flunarizine in cisplatin-induced acute renal failure via mitochondrial permeability transition pore inactivation in rats. Naunyn-Schmiedeberg's archives of pharmacology. 2011 Jan; 383(1):57-64. doi: 10.1007/s00210-010-0572-z. [PMID: 21058009]
  • Na Chi, Xing Tang, Hui Xu. Development and optimization of chemically stable lipid microspheres containing flunarizine. Drug development and industrial pharmacy. 2009 Jun; 35(6):738-45. doi: 10.1080/03639040802537893. [PMID: 19514990]
  • Yan Zhang, Linpeng Wang, Huilin Liu, Nan Li, Jingdao Li, Jinghong Yi. The design and protocol of acupuncture for migraine prophylaxis: a multicenter randomized controlled trial. Trials. 2009 Apr; 10(?):25. doi: 10.1186/1745-6215-10-25. [PMID: 19389262]
  • HongSeob So, HyungJin Kim, Yunha Kim, Eunsook Kim, Hyun-Ock Pae, Hun-Taeg Chung, Hye-Jung Kim, Kang-Beom Kwon, Kang-Min Lee, Haa-Yung Lee, Sung-Kyun Moon, Raekil Park. Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. Journal of the Association for Research in Otolaryngology : JARO. 2008 Sep; 9(3):290-306. doi: 10.1007/s10162-008-0126-y. [PMID: 18584244]
  • Xiaodong She, Lili Wu, Huilin Wei, Weida Liu, Yun Chen. Determination of oxatomide in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. Biomedical chromatography : BMC. 2008 Jul; 22(7):746-52. doi: 10.1002/bmc.992. [PMID: 18348338]
  • Andrew L Greller, Allison R Hoffman, Chengcheng Liu, Gui-shuang Ying, Daljit K Vudathala, Gregory M Acland, András M Komáromy. Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs. American journal of veterinary research. 2008 Feb; 69(2):273-8. doi: 10.2460/ajvr.69.2.273. [PMID: 18241026]
  • Naoki Shiota, Masayuki Shimono, Shiho Tomioka, Kenichi Takano, Ayako Kato, Akihiro Kawakami, Takehiro Ishizuka. [A boy with nystagmus, refractory dystonia and apneic attack due to alternating hemiplegia of childhood]. No to hattatsu = Brain and development. 2007 Jul; 39(4):285-8. doi: . [PMID: 17633086]
  • Yan Jiao Wang, Juan Wang, Hong Yao Zhang, Hai Bing He, Xing Tang. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres. The Journal of pharmacy and pharmacology. 2007 Mar; 59(3):351-7. doi: 10.1211/jpp.59.3.0003. [PMID: 17331337]
  • Maurício Malavasi Ganança, Heloisa Helena Caovilla, Mário Sérgio Lei Munhoz, Cristina Freitas Ganança, Maria Leonor Garcia da Silva, Flavio Serafini, Fernando Freitas Ganança. Optimizing the pharmacological component of integrated balance therapy. Brazilian journal of otorhinolaryngology. 2007 Jan; 73(1):12-8. doi: 10.1016/s1808-8694(15)31116-2. [PMID: 17505593]
  • E A Granados Loarca. [Calcium antagonists in the urethral syndrome of women with urinary incontinence and urgency]. Actas urologicas espanolas. 2006 Apr; 30(4):406-8. doi: 10.1016/s0210-4806(06)73465-9. [PMID: 16838613]
  • M S Berilgen, S Bulut, M Gonen, A Tekatas, E Dag, B Mungen. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia : an international journal of headache. 2005 Nov; 25(11):1048-53. doi: 10.1111/j.1468-2982.2005.00956.x. [PMID: 16232156]
  • Sonia Gallego-Sandín, Jesús Novalbos, Aránzazu Rosado, María F Cano-Abad, Esperanza Arias, Francisco Abad-Santos, Antonio G García. Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. European journal of pharmacology. 2005 Sep; 520(1-3):1-11. doi: 10.1016/j.ejphar.2005.06.044. [PMID: 16153637]
  • Hong-Seob So, Channy Park, Hyung-Jin Kim, Jung-Han Lee, Sung-Yeol Park, Jai-Hyung Lee, Zee-Won Lee, Hyung-Min Kim, Federico Kalinec, David J Lim, Raekil Park. Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. Hearing research. 2005 Jun; 204(1-2):127-39. doi: 10.1016/j.heares.2005.01.011. [PMID: 15925198]
  • Zhongping John Lin, David Musiano, Anna Abbot, Linyee Shum. In vitro plasma protein binding determination of flunarizine using equilibrium dialysis and liquid chromatography-tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis. 2005 Apr; 37(4):757-62. doi: 10.1016/j.jpba.2004.10.050. [PMID: 15797798]
  • Xia Li, Zheng-Lin Jiang, Guo-Hua Wang, Ji-Wei Fan. Plasma vasopressin, an etiologic factor of motion sickness in rat and human?. Neuroendocrinology. 2005; 81(6):351-9. doi: 10.1159/000088991. [PMID: 16230861]
  • I Ciancarelli, M G Tozzi-Ciancarelli, C Di Massimo, C Marini, A Carolei. Flunarizine effects on oxidative stress in migraine patients. Cephalalgia : an international journal of headache. 2004 Jul; 24(7):528-32. doi: 10.1111/j.1468-2982.2003.00705.x. [PMID: 15196294]
  • Hiroshi Kuromi, Atsuko Honda, Yoshiaki Kidokoro. Ca2+ influx through distinct routes controls exocytosis and endocytosis at drosophila presynaptic terminals. Neuron. 2004 Jan; 41(1):101-11. doi: 10.1016/s0896-6273(03)00815-8. [PMID: 14715138]
  • Yue-hua Zhang, Wen-xiu Sun, Jiong Qin, Yu-wu Jiang, Xi-ru Wu. [Clinical characteristics of alternating hemiplegia of childhood in 13 patients]. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2003 Sep; 41(9):680-3. doi: NULL. [PMID: 14733811]
  • Adriana Maltese, Claudio Bucolo. Pharmacokinetic profile of topical flunarizine in rabbit eye and plasma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2003 Apr; 19(2):171-9. doi: 10.1089/108076803321637708. [PMID: 12804062]
  • Mariusz Swiader, Kinga K Borowicz, Jacek Porebiak, Zdzisław Kleinrok, Stanisław J Czuczwar. Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2002 Aug; 12(4):311-9. doi: 10.1016/s0924-977x(02)00045-7. [PMID: 12126870]
  • Celia M Santi, Francisco S Cayabyab, Kathy G Sutton, John E McRory, Janette Mezeyova, Kevin S Hamming, David Parker, Anthony Stea, Terrance P Snutch. Differential inhibition of T-type calcium channels by neuroleptics. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002 Jan; 22(2):396-403. doi: 10.1523/jneurosci.22-02-00396.2002. [PMID: 11784784]
  • K Aihara, H Azuma, Y Ikeda, M Akaike, M Abe, T Sugihara, T Matsumoto. Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia. International journal of hematology. 2001 Apr; 73(3):351-5. doi: 10.1007/bf02981961. [PMID: 11345202]
  • M A Wingertzahn, R S Ochs. Changes in ryanodine receptor-mediated calcium release during skeletal muscle differentiation. II. Resolution of a caffeine-ryanodine paradox. Experimental biology and medicine (Maywood, N.J.). 2001 Feb; 226(2):119-26. doi: 10.1177/153537020122600209. [PMID: 11446435]
  • C B Matthew, I V Sils. Flunarizine pretreatment attenuates hyperthermia-induced extravasation in rats. Pflugers Archiv : European journal of physiology. 2000 Nov; 441(1):88-93. doi: 10.1007/s004240000398. [PMID: 11205066]
  • T M Mamic, N A Holman, S J Roberts-Thomson, G R Monteith. PMCA1 mRNA expression in rat aortic myocytes: a real-time RT-PCR study. Biochemical and biophysical research communications. 2000 Oct; 276(3):1024-7. doi: 10.1006/bbrc.2000.3578. [PMID: 11027585]
  • C Patrat, C Serres, P Jouannet. Induction of a sodium ion influx by progesterone in human spermatozoa. Biology of reproduction. 2000 May; 62(5):1380-6. doi: 10.1095/biolreprod62.5.1380. [PMID: 10775190]
  • H Hara, M Shimazawa, M Sasaoka, C Yamada, Y Iwakura, T Sakai, Y Maeda, T Yamaguchi, T Sukamoto, M Hashimoto. Selective effects of lomerizine, a novel diphenylmethylpiperazine Ca2+ channel blocker, on cerebral blood flow in rats and dogs. Clinical and experimental pharmacology & physiology. 1999 Nov; 26(11):870-6. doi: 10.1046/j.1440-1681.1999.03154.x. [PMID: 10561807]
  • R Nuydens, J Novalbos, G Dispersyn, C Weber, M Borgers, H Geerts. A rapid method for the evaluation of compounds with mitochondria-protective properties. Journal of neuroscience methods. 1999 Oct; 92(1-2):153-9. doi: 10.1016/s0165-0270(99)00107-7. [PMID: 10595713]
  • O Terland, T Flatmark. Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles. Neuropharmacology. 1999 Jun; 38(6):879-82. doi: 10.1016/s0028-3908(98)00233-0. [PMID: 10465691]
  • G S Schierle, P Brundin. Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium. Experimental neurology. 1999 Jun; 157(2):338-48. doi: 10.1006/exnr.1999.7066. [PMID: 10364445]
  • S J Millward-Sadler, M O Wright, H Lee, K Nishida, H Caldwell, G Nuki, D M Salter. Integrin-regulated secretion of interleukin 4: A novel pathway of mechanotransduction in human articular chondrocytes. The Journal of cell biology. 1999 Apr; 145(1):183-9. doi: 10.1083/jcb.145.1.183. [PMID: 10189377]
  • J Novalbos, F Abad-Santos, P Zapater, M F Cano-Abad, J Moradiellos, P Sánchez-García, A G García. Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+. European journal of pharmacology. 1999 Feb; 366(2-3):309-17. doi: 10.1016/s0014-2999(98)00916-9. [PMID: 10082213]
  • G S Kaminski Schierle, O Hansson, P Brundin. Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience. 1999; 94(1):17-20. doi: 10.1016/s0306-4522(99)00324-3. [PMID: 10613492]
  • M Akisü, N Kültürsay, I Coker, A Hüseyinov. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biology of the neonate. 1998 Dec; 74(6):439-44. doi: 10.1159/000014065. [PMID: 9784635]
  • I Mahmood, V K Tammara, R K Baweja. Does percent reduction in seizure frequency correlate with plasma concentration of anticonvulsant drugs? Experience with four anticonvulsant drugs. Clinical pharmacology and therapeutics. 1998 Nov; 64(5):547-52. doi: 10.1016/s0009-9236(98)90138-2. [PMID: 9834047]
  • Y Xian, T Lan, Y Wang. [Protective effects of flunarizine and vitamin C on isolated rat heart subjected to ischemia-reperfusion injury]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao. 1998 Jun; 29(2):155-9. doi: ". [PMID: 10684005]
  • A Elimadi, L Bouillot, R Sapena, J P Tillement, D Morin. Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition. European journal of pharmacology. 1998 May; 348(1):115-21. doi: 10.1016/s0014-2999(98)00135-6. [PMID: 9650838]
  • Y Garnier, R Berger, D Pfeiffer, A Jensen. Low-dose flunarizine does not affect short-term fetal circulatory responses to acute asphyxia in sheep near term. Reproduction, fertility, and development. 1998; 10(5):405-11. doi: 10.1071/rd97081. [PMID: 10461673]
  • G Blackburn-Munro, S M Fleetwood-Walker. The effects of Na+ channel blockers on somatosensory processing by rat dorsal horn neurones. Neuroreport. 1997 May; 8(7):1549-54. doi: 10.1097/00001756-199705060-00001. [PMID: 9189890]
  • I Mahmood, J T Sahlroot. A limited sampling method for the estimation of flunarizine area under the curve (AUC) and maximum plasma concentration (Cmax). Biopharmaceutics & drug disposition. 1997 Mar; 18(2):117-26. doi: 10.1002/(sici)1099-081x(199703)18:2<117::aid-bdd5>3.0.co;2-c. [PMID: 9099448]
  • L Zhang, L Cai, W Zhang. [A pathological survey of the therapeutic effect on experimental hypoxic-ischemic encephalopathy]. Zhonghua bing li xue za zhi = Chinese journal of pathology. 1996 Apr; 25(2):102-4. doi: ". [PMID: 9206216]
  • M Gasior, R Kamiński, T Brudniak, Z Kleinrok, S J Czuczwar. Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. Journal of neural transmission (Vienna, Austria : 1996). 1996; 103(7):819-31. doi: 10.1007/bf01273360. [PMID: 8872866]
  • S Kariya, S Isozaki, Y Masubuchi, T Suzuki, S Narimatsu. Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine. Biochemical pharmacology. 1995 Nov; 50(10):1645-50. doi: 10.1016/0006-2952(95)02057-8. [PMID: 7503767]
  • K Hoppu, A R Nergårdh, A S Eriksson, O Beck, E Forssblad, L O Boréus. Flunarizine of limited value in children with intractable epilepsy. Pediatric neurology. 1995 Sep; 13(2):143-7. doi: 10.1016/0887-8994(95)00142-3. [PMID: 8534279]
  • M Gasior, Z Kleinrok, S J Czuczwar. Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional anti-epileptics against electroconvulsions in mice. Neuropharmacology. 1995 Apr; 34(4):433-8. doi: 10.1016/0028-3908(95)00004-p. [PMID: 7566475]
  • A Handforth, T Mai, D M Treiman. Rising dose study of safety and tolerance of flunarizine. European journal of clinical pharmacology. 1995; 49(1-2):91-4. doi: 10.1007/bf00192365. [PMID: 8751028]
  • G W Pledger, J C Sackellares, D M Treiman, J M Pellock, F S Wright, M Mikati, J T Sahlroot, J Y Tsay, M E Drake, L Olson. Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Neurology. 1994 Oct; 44(10):1830-6. doi: 10.1212/wnl.44.10.1830. [PMID: 7936231]
  • C Ito, W B Im, H Takagi, M Takahashi, K Tsuzuki, S Y Liou, M Kunihara. U-92032, a T-type Ca2+ channel blocker and antioxidant, reduces neuronal ischemic injuries. European journal of pharmacology. 1994 May; 257(3):203-10. doi: 10.1016/0014-2999(94)90130-9. [PMID: 8088342]
  • D L Santos, M C Lopes, C M Carvalho. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes. European journal of pharmacology. 1994 May; 267(3):307-16. doi: 10.1016/0922-4106(94)90155-4. [PMID: 8088369]
  • S Nevsímalová, J Dittrich, M Havlová, A Tauberová, B Korsová, M Hájek, J Masopust, K Michalová. Alternating hemiplegia in childhood: a cross-sectional study. Brain & development. 1994 May; 16(3):189-94. doi: 10.1016/0387-7604(94)90068-x. [PMID: 7943602]
  • D M Treiman, G W Pledger, C DeGiorgio, J Y Tsay, J J Cereghino. Increasing plasma concentration tolerability study of flunarizine in comedicated epileptic patients. Epilepsia. 1993 Sep; 34(5):944-53. doi: 10.1111/j.1528-1157.1993.tb02116.x. [PMID: 8404751]
  • T Suzuki, H Mizoguchi, H Noguchi, T Yoshii, M Misawa. Effects of flunarizine and diltiazem on physical dependence on barbital in rats. Pharmacology, biochemistry, and behavior. 1993 Jul; 45(3):703-12. doi: 10.1016/0091-3057(93)90528-2. [PMID: 8392734]
  • M Bialer. Comparative pharmacokinetics of the newer antiepileptic drugs. Clinical pharmacokinetics. 1993 Jun; 24(6):441-52. doi: 10.2165/00003088-199324060-00002. [PMID: 8513648]
  • P G Thomas, J Seelig. Binding of the calcium antagonist flunarizine to phosphatidylcholine bilayers: charge effects and thermodynamics. The Biochemical journal. 1993 Apr; 291 ( Pt 2)(?):397-402. doi: 10.1042/bj2910397. [PMID: 8484720]
  • T M Lo, S A Thayer. Refilling the inositol 1,4,5-trisphosphate-sensitive Ca2+ store in neuroblastoma x glioma hybrid NG108-15 cells. The American journal of physiology. 1993 Mar; 264(3 Pt 1):C641-53. doi: 10.1152/ajpcell.1993.264.3.c641. [PMID: 8460669]
  • E Stoica, O Enulescu. The influence of amitriptyline and flunarizine on catecholamine response to light in patients with migraine. Romanian journal of neurology and psychiatry = Revue roumaine de neurologie et psychiatrie. 1993 Jan; 31(1):11-9. doi: . [PMID: 8363973]
  • T Shiraishi, T Kubo, S Okumura, H Naramura, M Nishimura, M Okusa, T Matsunaga. Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy. Acta oto-laryngologica. Supplementum. 1993; 501(?):46-50. doi: 10.3109/00016489309126213. [PMID: 7680521]
  • M A Mikati, H Maguire, C F Barlow, L Ozelius, X O Breakefield, S M Klauck, B Korf, S L O'Tuama, F Dangond. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy; chromosomal studies; and physiologic investigations. Neurology. 1992 Dec; 42(12):2251-7. doi: 10.1212/wnl.42.12.2251. [PMID: 1361034]
  • S J Czuczwar, M Gasior, W Janusz, Z Kleinrok. Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology. 1992 Nov; 31(11):1179-83. doi: 10.1016/0028-3908(92)90015-h. [PMID: 1475024]
  • F Ohshima, Y Masuda, M Kodaira, M Fukayama, T Inamatsu, H Nagura. [A case report of severe urinary retention and meteorism during flunarizine administration]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. 1992 Mar; 29(3):198-201. doi: 10.3143/geriatrics.29.198. [PMID: 1593790]
  • A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke, R W Schrier. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury. The Journal of pharmacology and experimental therapeutics. 1992 Feb; 260(2):526-32. doi: NULL. [PMID: 1738102]
  • G B De Sarro, A De Sarro, G R Trimarchi, G Nistico'. Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2 mice. General pharmacology. 1992 Jan; 23(1):75-82. doi: 10.1016/0306-3623(92)90051-k. [PMID: 1375572]
  • D J Honess, N M Bleehen. Effects of calcium channel blockers on renal function in mice. International journal of radiation oncology, biology, physics. 1992; 22(3):443-6. doi: 10.1016/0360-3016(92)90849-d. [PMID: 1735675]
  • G W Pledger, D M Treiman. Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration. Controlled clinical trials. 1991 Dec; 12(6):768-79. doi: 10.1016/0197-2456(91)90040-s. [PMID: 1665118]
  • S Nag. Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats. Stroke. 1991 Oct; 22(10):1265-9. doi: 10.1161/01.str.22.10.1265. [PMID: 1926237]
  • A Battaglia, A R Ferrari, R Guerrini. Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy. Brain & development. 1991 Jul; 13(4):217-22. doi: 10.1016/s0387-7604(12)80052-0. [PMID: 1957968]
  • D P Edward, T T Lam, S Shahinfar, J Li, M O Tso. Amelioration of light-induced retinal degeneration by a calcium overload blocker. Flunarizine. Archives of ophthalmology (Chicago, Ill. : 1960). 1991 Apr; 109(4):554-62. doi: 10.1001/archopht.1991.01080040122042. [PMID: 2012559]
  • H P Rolzhäuser, W Oestreich, K U Seiler, T Peters, D Platt, D Jorisch. [Pharmacokinetics and pharmacodynamics of flunarizine in multimorbid, geriatric patients with vertigo]. Arzneimittel-Forschung. 1991 Feb; 41(2):109-14. doi: NULL. [PMID: 2043170]
  • P J Van Reempts, K J Boven, S E Spitaels, A M Roodhooft, E L Vercruyssen, K J Van Acker. Idiopathic arterial calcification of infancy. Calcified tissue international. 1991 Jan; 48(1):1-6. doi: 10.1007/bf02555789. [PMID: 2007222]
  • P G Thomas, A J Verkleij. The dissimilar interactions of the calcium antagonist flunarizine with different phospholipid classes and molecular species: a differential scanning calorimetry study. Biochimica et biophysica acta. 1990 Dec; 1030(2):211-22. doi: 10.1016/0005-2736(90)90297-2. [PMID: 2261484]
  • U Henseleit, G Plasa, C Haest. Effects of divalent cations on lipid flip-flop in the human erythrocyte membrane. Biochimica et biophysica acta. 1990 Nov; 1029(1):127-35. doi: 10.1016/0005-2736(90)90445-t. [PMID: 2223803]
  • B van Ooijen, W J Kort, C J Tinga, J H Wilson. Significance of thromboxane A2 and prostaglandin I2 in acute necrotizing pancreatitis in rats. Digestive diseases and sciences. 1990 Sep; 35(9):1078-84. doi: 10.1007/bf01537578. [PMID: 1697236]
  • H Waki, K Kon, Y Tanaka, S Ando. Age-related changes in the uptake of calcium channel blockers by brain capillary endothelial cells and synaptosomal fractions. Neuroscience letters. 1990 Aug; 116(3):367-71. doi: 10.1016/0304-3940(90)90103-g. [PMID: 2243616]
  • F Albani, A Baldrati, P Cortelli, R Riva, A Baruzzi. Flunarizine plasma concentrations and side effects in migraine patients. Headache. 1990 May; 30(6):369-70. doi: 10.1111/j.1526-4610.1990.hed3006369.x. [PMID: 2370140]
  • L Ver Donck, G Verellen, R Vandewiele, F De Clerck, M Borgers. Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes. Cell biology international reports. 1990 Apr; 14(4):399-406. doi: 10.1016/0309-1651(90)91209-m. [PMID: 2354524]
  • S Nag, L Young. Cerebrovascular permeability in acute hypertension: effect of flunarizine. Acta neurochirurgica. Supplementum. 1990; 51(?):344-5. doi: 10.1007/978-3-7091-9115-6_116. [PMID: 2089934]
  • A Marzo, E Treffner, G Meroni, M Ripamonti, R Pelloso, C Lucarelli. Assay of a calcium antagonist (PU 122) in plasma by gas chromatography. Journal of chromatography. 1989 Dec; 497(?):296-301. doi: 10.1016/0378-4347(89)80032-5. [PMID: 2625466]
  • P E Schwabedal, G Brügging-Schmitz, W Oestreich, S C Szathmary. Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 1989 Dec; 7(6):S280-1. doi: 10.1097/00004872-198900076-00136. [PMID: 2632726]
  • P J Pauwels, H P Van Assouw, J E Leysen, P A Janssen. Ca2+-mediated neuronal death in rat brain neuronal cultures by veratridine: protection by flunarizine. Molecular pharmacology. 1989 Oct; 36(4):525-31. doi: . [PMID: 2554110]
  • L Somova, G Dashev, G Kirilov, R Nikolov, M Doncheva, M Vassileva. Streptozotocin-induced diabetes in rat. III. Antioxidant protection of vascular complications by flunarizine and aligeron. Methods and findings in experimental and clinical pharmacology. 1989 Oct; 11(10):607-12. doi: NULL. [PMID: 2531258]
  • C M Carvalho, C R Oliveira, M P Lima, J E Leysen, A P Carvalho. Partition of Ca2+ antagonists in brain plasma membranes. Biochemical pharmacology. 1989 Jul; 38(13):2121-7. doi: 10.1016/0006-2952(89)90066-x. [PMID: 2735950]
  • B van Ooijen, W J Kort, C J Tinga, J H Wilson, D L Westbroek. Significance of prostaglandin E2 in acute necrotising pancreatitis in rats. Gut. 1989 May; 30(5):671-4. doi: 10.1136/gut.30.5.671. [PMID: 2731761]